Both in Pharmaceuticals
Edesa Biotech vs Atossa Therapeutics
Over the past year EDSA returned +26.4% and ATOS returned −82.7%; their daily moves had a correlation of 0.03.
EDSA +26.4% ATOS −82.7%Growth of $1, one year, split-adjusted
| Metric | EDSA | ATOS |
|---|---|---|
| Price | $2.20 | $2.24 |
| Market cap | $21.2M | $22.4M |
| Today | −3.51% | −3.68% |
| 1 month | −40.9% | −8.4% |
| 6 months | −85.3% | −61.3% |
| Year to date | +54.9% | −74.6% |
| 1 year | +26.4% | −82.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.3M | $26.1M |
| Dividend yield | — | — |
| Volatility (60d) | 88.5% | 77.0% |
| Short % of float | 2.3% | 7.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).